Halozyme Therapeutics Inc. (HALO)

$ 70.31
   
  • Change Today:
    $3.01
  • 52 Week High: $70.35
  • 52 Week Low: $67.16
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 2,441,343
  • Market Cap: $10,216m
  • RiskGrade: 189

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 1,675.93 1,089.16 813.00¢ 8.6 0.3 +30% n/a 0.0%
31-Dec-27 1,887.98 1,296.54 955.50¢ 7.4 0.4 +18% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 70.31
Change Today $ 3.01
% Change 4.47 %
52 Week High $70.35
52 Week Low $67.16
Volume 2,441,343
Shares Issued 145.30m
Market Cap $10,216m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 2
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 02-Jan-2026

Time Volume / Share Price
16:00 100 @ $70.29
16:00 235,560 @ $70.31
15:59 194 @ $70.29
15:59 109 @ $70.29
15:59 100 @ $70.29

Top of Page